Shuhei Komatsu

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 16

Top Venues

British journal of cancer

Cancer science

Annals of gastroenterological surgery

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Rie Shibata, Hirotaka Konishi, Tomohiro Arita, Yusuke Yamamoto, Hayato Matsuda, Taiga Yamamoto, Takuma Ohashi, Hiroki Shimizu, Shuhei Komatsu, Atsushi Shiozaki, Takeshi Kubota, Hitoshi Fujiwara, Eigo Otsuji
Extracellular glypican-1 affects tumor progression and prognosis in esophageal cancer. Cancer medicine 13 (18) (2024)
Hajime Kamiya, Shuhei Komatsu, Yusuke Takashima, Ryo Ishida, Hiroshi Arakawa, Keiji Nishibeppu, Jun Kiuchi, Taisuke Imamura, Takuma Ohashi, Hiroki Shimizu, Tomohiro Arita, Hirotaka Konishi, Atsushi Shiozaki, Takeshi Kubota, Hitoshi Fujiwara, Shigeki Yagyu, Tomoko Iehara, Eigo Otsuji
Low blood level of tumour suppressor miR-5193 as a target of immunotherapy to PD-L1 in gastric cancer. British journal of cancer (2023)
Hajime Kamiya, Shuhei Komatsu, Yusuke Takashima, Ryo Ishida, Hiroshi Arakawa, Keiji Nishibeppu, Jun Kiuchi, Taisuke Imamura, Takuma Ohashi, Hiroki Shimizu, Tomohiro Arita, Hirotaka Konishi, Atsushi Shiozaki, Takeshi Kubota, Hitoshi Fujiwara, Shigeki Yagyu, Tomoko Iehara, Eigo Otsuji
Low blood level of tumour suppressor miR-5193 as a target of immunotherapy to PD-L1 in gastric cancer. British journal of cancer 130 (4) (2023)
Hajime Kamiya, Shuhei Komatsu, Yusuke Takashima, Ryo Ishida, Hiroshi Arakawa, Keiji Nishibeppu, Jun Kiuchi, Taisuke Imamura, Takuma Ohashi, Hiroki Shimizu, Tomohiro Arita, Hirotaka Konishi, Atsushi Shiozaki, Takeshi Kubota, Hitoshi Fujiwara, Shigeki Yagyu, Tomoko Iehara, Eigo Otsuji
Low blood level of tumour suppressor miR-5193 as a target of immunotherapy to PD-L1 in gastric cancer. British journal of cancer 130 (4) (2023)
Hajime Kamiya, Shuhei Komatsu, Yusuke Takashima, Ryo Ishida, Hiroshi Arakawa, Keiji Nishibeppu, Jun Kiuchi, Taisuke Imamura, Takuma Ohashi, Hiroki Shimizu, Tomohiro Arita, Hirotaka Konishi, Atsushi Shiozaki, Takeshi Kubota, Hitoshi Fujiwara, Shigeki Yagyu, Tomoko Iehara, Eigo Otsuji
Low blood level of tumour suppressor miR-5193 as a target of immunotherapy to PD-L1 in gastric cancer. British journal of cancer 130 (4) (2023)
Hajime Kamiya, Shuhei Komatsu, Yusuke Takashima, Ryo Ishida, Hiroshi Arakawa, Keiji Nishibeppu, Jun Kiuchi, Taisuke Imamura, Takuma Ohashi, Hiroki Shimizu, Tomohiro Arita, Hirotaka Konishi, Atsushi Shiozaki, Takeshi Kubota, Hitoshi Fujiwara, Shigeki Yagyu, Tomoko Iehara, Eigo Otsuji
Low blood level of tumour suppressor miR-5193 as a target of immunotherapy to PD-L1 in gastric cancer. British journal of cancer 130 (4) (2023)
Yusuke Takashima, Shuhei Komatsu, Takuma Ohashi, Jun Kiuchi, Keiji Nishibeppu, Hajime Kamiya, Hiroshi Arakawa, Ryo Ishida, Hiroki Shimizu, Tomohiro Arita, Hirotaka Konishi, Atsushi Shiozaki, Takeshi Kubota, Hitoshi Fujiwara, Eigo Otsuji
Plasma miR-1254 as a predictive biomarker of chemosensitivity and a target of nucleic acid therapy in esophageal cancer. Cancer science (2023)
Hajime Kamiya, Shuhei Komatsu, Yusuke Takashima, Ryo Ishida, Hiroshi Arakawa, Keiji Nishibeppu, Jun Kiuchi, Taisuke Imamura, Takuma Ohashi, Hiroki Shimizu, Tomohiro Arita, Hirotaka Konishi, Atsushi Shiozaki, Takeshi Kubota, Hitoshi Fujiwara, Shigeki Yagyu, Tomoko Iehara, Eigo Otsuji
Low blood level of tumour suppressor miR-5193 as a target of immunotherapy to PD-L1 in gastric cancer. British journal of cancer 130 (4) (2023)
Hajime Kamiya, Shuhei Komatsu, Yusuke Takashima, Ryo Ishida, Hiroshi Arakawa, Keiji Nishibeppu, Jun Kiuchi, Taisuke Imamura, Takuma Ohashi, Hiroki Shimizu, Tomohiro Arita, Hirotaka Konishi, Atsushi Shiozaki, Takeshi Kubota, Hitoshi Fujiwara, Shigeki Yagyu, Tomoko Iehara, Eigo Otsuji
Low blood level of tumour suppressor miR-5193 as a target of immunotherapy to PD-L1 in gastric cancer. British journal of cancer 130 (4) (2023)
Hirotaka Furuke, Hirotaka Konishi, Tomohiro Arita, Satoshi Kataoka, Jun Shibamoto, Kazuya Takabatake, Wataru Takaki, Hiroki Shimizu, Yusuke Yamamoto, Shuhei Komatsu, Atsushi Shiozaki, Hitoshi Fujiwara, Eigo Otsuji
Plasma microRNA-192-5p can predict the response to neoadjuvant chemotherapy and prognosis in esophageal cancer. Cancer science (2022)
Yusuke Takashima, Shuhei Komatsu, Takuma Ohashi, Jun Kiuchi, Hajime Kamiya, Hiroki Shimizu, Tomohiro Arita, Hirotaka Konishi, Atsushi Shiozaki, Takeshi Kubota, Kazuma Okamoto, Hitoshi Fujiwara, Hitoshi Tsuda, Eigo Otsuji
Overexpression of Tetraspanin31 contributes to malignant potential and poor outcomes in gastric cancer. Cancer science 113 (6) (2022)
Hirotaka Furuke, Hirotaka Konishi, Tomohiro Arita, Satoshi Kataoka, Jun Shibamoto, Kazuya Takabatake, Wataru Takaki, Hiroki Shimizu, Yusuke Yamamoto, Shuhei Komatsu, Atsushi Shiozaki, Hitoshi Fujiwara, Eigo Otsuji
Plasma microRNA-192-5p can predict the response to neoadjuvant chemotherapy and prognosis in esophageal cancer. Cancer science (2022)
Keita Katsurahara, Atsushi Shiozaki, Toshiyuki Kosuga, Hiroki Shimizu, Michihiro Kudou, Tomohiro Arita, Hirotaka Konishi, Shuhei Komatsu, Takeshi Kubota, Hitoshi Fujiwara, Kazuma Okamoto, Mitsuo Kishimoto, Eiichi Konishi, Eigo Otsuji
ANO9 regulates PD-L2 expression and binding ability to PD-1 in gastric cancer. Cancer science 112 (3) (2021)
Kenji Nanishi, Hirotaka Konishi, Katsutoshi Shoda, Tomohiro Arita, Toshiyuki Kosuga, Shuhei Komatsu, Atsushi Shiozaki, Takeshi Kubota, Hitoshi Fujiwara, Kazuma Okamoto, Daisuke Ichikawa, Eigo Otsuji
Circulating circERBB2 as a potential prognostic biomarker for gastric cancer: An investigative study. Cancer science 111 (11) (2020)
Shuhei Komatsu, Eigo Otsuji
Essential updates 2017/2018: Recent topics in the treatment and research of gastric cancer in Japan. Annals of gastroenterological surgery 3 (6) (2019)
Shinpei Ogino, Hirotaka Konishi, Daisuke Ichikawa, Daiki Matsubara, Katsutoshi Shoda, Tomohiro Arita, Toshiyuki Kosuga, Shuhei Komatsu, Atsushi Shiozaki, Kazuma Okamoto, Mitsuo Kishimoto, Eigo Otsuji
Glutathione S-transferase Pi 1 is a valuable predictor for cancer drug resistance in esophageal squamous cell carcinoma. Cancer science 110 (2) (2018)

Shuhei Komatsu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Shuhei Komatsu